Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

People with Chronic Telogen Effluvium mainly have lower iron levels compared to healthy individuals.

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

SHBG may be a useful early indicator and treatment target for PCOS.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Women with acromegaly often have irregular periods due to hormone imbalances and growth hormone effects.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Menopause can lead to skin and hair problems due to hormonal changes, but hormone replacement therapy might help slow these effects.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Menopause causes significant changes in the vaginal introitus, but less so in the labia majora, which may lead to symptoms of vaginal atrophy.

High levels of testosterone and anti-Müllerian hormone before pregnancy are linked to a higher risk of newborns needing intensive care.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

The document concludes that skin aging in women can be caused by UV exposure and hormonal changes, and treatments like hormone replacement therapy and various skin therapies can help.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.